TP53 and neoplasm: Notably, the FEO-CSNPs significantly downregulated key oncogenes such as PIK3CA, CCDN1, HER2, and WNT1, while upregulating the tumor suppressors TP53 and CDH1, indicating their potent anti-cancer activity.